JamieLynnFeltonMD

Pediatric Endocrinology • Indianapolis, IN

Physician

Join to view full profile

Dr. Felton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Felton's full profile

Already have an account?

Office
705 Riley Hospital Dr
# RI5960
Indianapolis, IN 46202
Phone+1 317-944-3889

Fax+1 317-944-3882

Education & Training

Vanderbilt University Medical CenterFellowship, Pediatric Endocrinology, 2014 - 2017
University of North Carolina HospitalsResidency, Pediatrics, 2011 - 2014
The University of Texas Health Science Center at San AntonioClass of 2011

Certifications & Licensure

IN State Medical License 2018 - 2025
TN State Medical License 2014 - 2020
NC State Medical License 2011 - 2014
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Endocrinology

Publications & Presentations

PubMed

Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice.
Farooq Syed, Olivia Ballew, Chih-Chun Lee, Jyoti Rana, Preethi Krishnan
Biorxiv. 2024-05-09
6 citations
Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review.
Jamie L Felton, Maria J Redondo, Richard A Oram, Cate Speake, S Alice Long
Communications Medicine. 2024-04-06
8 citations
Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review.
Jamie L Felton, Kurt J Griffin, Richard A Oram, Cate Speake, S Alice Long
Communications Medicine. 2023-10-05

Journal Articles

Anti-Insulin B Cells Are Poised for Antigen Presentation in Type 1 Diabetes
Jamie L Felton, James W Thomas, The Journal of Immunology

Press Mentions

IU Research Contributes to First FDA-approved Drug to Delay Onset of Type 1 DiabetesNovember 21st, 2022
Fishers Boy First in Indiana to Receive Newly Approved Drug That Delays Onset of Type 1 DiabetesSeptember 1st, 2023